Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the September 12, 2014 Federal Register, FDA
withdrew approval of three abbreviated new drug applications
("ANDAs") for products containing propoxyphene. FDA found
the products are no longer shown to be safe due to risks of
potentially serious and even fatal heart rhythm abnormalities. The
holders of these ANDAs waived their opportunity for a hearing.
Effective September 12, 2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
